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Abstract
Purpose
To determine the structural changes in the choroid after half-dose photodynamic therapy
(hPDT) in eyes with chronic central serous chorioretinopathy (CSC).
Methods
This was a retrospective interventional study of 29 eyes of 29 patients who underwent
hPDT for chronic CSC with serous retinal detachment (SRD) and were followed for3
months. Enhanced depth imaging optical coherence tomographic (EDI-OCT) images of the
subfoveal choroid were converted to binary images. The central choroidal thickness (CCT),
the cross sectional subfoveal choroidal area, the hyporeflective and hyperreflective areas of
the inner, outer, and whole choroid were determinedat the baseline, and at 1, 3, and 12
months after the hPDT.
Results
The SRDs were resolved in 26 (89.7%) eyes at 3 months after the hPDT. Themean CCT
(P = 0.001), the total choroidal area (P = 0.001), and the hypo-reflective area (P = 0.003) of
the whole choroid were significantly decreased from the baseline at 3 months. The hyperre-
flective area of whole choroid was not significantly changed during the study period (P =
0.083). The hyperreflective but not the hyporeflective area of the inner choroid was signifi-
cantly decreased at 3 months (P = 0.001,P = 1.000, respectively). The hyporeflective but
not the hyperreflective area of the outer choroid was significantly decreased at 3 months
(P = 0.001,P = 1.000, respectively).
Conclusions
The hyperreflective area of the inner choroid and hyporeflective area of the outer choroid
were significantly decreased after hPDT for chronic CSC. Because the hyperreflective and
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hyporeflective area correspond to the choroidal stroma and vessels, respectively, the
decreased CCT and subfoveal choroidal area after hPDTmay be attributed to a decrease in
the exudative changes in the inner choroidal stroma and the reduction of the dilation of the
outer choroidal vessels.
Introduction
Recent studies using enhanced depth imaging optical coherence tomography (EDI-OCT) or
swept-source OCT have shown that the choroid is closely associated with the pathogenesis of
various retinal diseases [1–6]. Central serous chorioretinopathy (CSC) is believed to be one
of those diseases in which abnormalities in the choroid such as an abnormal ocular circula-
tion and an increased vascular permeability can cause a thickening of the choroid and an
increase in the hydrostatic pressure which can lead to a disruption of the retinal pigment epi-
thelium and the development of a serous retinal detachment (SRD) [1,2,7–11]. Although
CSC usually resolves spontaneously in a few months, persistent or recurrent SRDs can lead
to a permanent reduction of vision [12,13].
Photodynamic therapy (PDT) has been shown to be effective in treating chronic CSC [14–
16], and modifiedPDT such as half-dose PDT (hPDT) [17–21] or reduced-fluencePDT
[19,22–25] led to favorable results with less complications. The thickening of the choroid
decreases after hPDT [2,25]. However, because a layer-by-layer architecture is not distinct in
choroid, the changes in detailed choroidal structures except for the thickness and area have not
been determined in these eyes.
We have recently reported on a newmethod to differentiate and quantify the choroidal
lumens from the stroma using an open access software named ImageJ [26–33]. Earlier studies
and many empirical observations strongly suggested that the hyporeflective areas in the
EDI-OCT images represented the luminal or fluid-filled areas and that the hyperreflective
areas represented the stromal areas [34–36]. We used the binarization technique to differen-
tiate the choroidal luminal area from the stromal area, and we reported that not only the cho-
roidal thickness but also the ratio of luminal area to total choroidal area decreased
significantly with aging and longer axial lengths in normal eyes [27]. The choroidal thickness
and the ratio of the luminal area to the total choroidal area also decreased after PDT in eyes
with age-related macular degeneration and after corticosteroidal therapy in eyes with Vogt-
Koyanagi-Harada disease [26,28].
In eyes with CSC, the ratio of the hyporeflective area to the total choroidal area was signifi-
cantly larger than that of normal eyes, and the ratio in the fellow eyes of the patients with uni-
lateral CSC was significantly larger than that of normal eyes [33,37]. Knowledge of the sizes
and ratios of the luminal and stromal areas in CSC eyes before and after hPDT should be useful
for understanding the pathogenesis of CSC.
Thus, the purpose of this study was to determine the changes in the hyporeflective and
hyperreflective areas of the choroid in eyes with chronic CSC before and after hPDT by binariz-
ing of the EDI-OCT images.
Methods
The procedures used conformed to the tenets of the Declaration of Helsinki, and a written
informed consent was obtained from all of the patients after the intent of the study had been
fully explained. An approval was obtained from the Institutional ReviewBoard of Tokushima
University Hospital for the study protocol.
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Inclusion and exclusion criteria
This was a retrospective, consecutive case series of 29 eyes of 29 patients who underwent hPDT
for a chronic CSC at the Tokushima University Hospital betweenApril 2013 and April 2016.
The eyes with chronic CSC were defined as eyes with a SRD that was detected by spectral-
domain OCT (SD-OCT) to have persisted for more than 6 months with areas of alterations in
the retinal pigment epithelium such as depigmentation or retinal pigment epithelial detach-
ment. Fluorescein angiography (FA) of these eyes showed diffuse or multiple areas of granular
hyperfluorescence and indistinct leakage [38].
The inclusion criteria were patients with chronic CSC associated with a SRD involving
the fovea who had undergone hPDT and were followed for at least 3 months. Forty-one eyes
of 39 patients were screened for the possible enrollment for the study. Twelve eyes were
excluded from the study. The exclusion criteria included; (1) best-corrected visual acuity
(BCVA) >1.0 logarithm of the minimum angle of resolution (logMAR) units (1 eye), (2)
eyes with polypoidal vasculopathy (3 eyes), (3) high myopia defined as a refractive error
(spherical equivalent)< -6.0 diopters or an axial length>26.5 mm (1 eye), (4) patients
under corticosteroid therapy (1 eye), (5) patients with other ocular diseases that may affect
the visual acuity or clinical findings (1 eye), (6) patients who had undergone intraocular sur-
geries including laser photocoagulation (3 eyes), and (7) patients who received hPDT for
bilateral chronic CSC (4 eyes). Two of 4 eyes treated with hPDT for bilateral chronic CSC
had also undergone laser photocoagulation. There were 2 patients with diabetes mellitus.
These two patients were excluded because of a moderate cataract and a history of intraocular
surgery. There were 2 smokers in the 39 patients screened. These two patients were excluded
because of polypoidal vasculopathy and bilateral chronic CSC treated with hPDT. Twelve
patients with well-controlled hypertension and 4 patients with well-controlled hyperlipid-
emia were included. In the end, 29 eyes of 29 patients were studied. The untreated fellow
eyes without SRD were used as controls.
Ophthalmic examinations
The ophthalmic examinations used for the diagnosis of CSC includedmeasurements of the
BCVA and the intraocular pressure, slit-lamp biomicroscopy, indirect ophthalmoscopy, fun-
dus photography, FA (TRC50DX, TOPCON, Tokyo, Japan), indocyanine angiography (IA;
TRC50DX, TOPCON), and SD-OCT (Spectralis OCT, Heidelberg Engineering,Heidelberg,
Germany). The measurements were performed before and at 1, 3, and 12 months after the
half-dose PDT. FA and IA were performed at the baseline. IA was performed to identify the
areas of choroidal hyperpermeability which was used for the diagnosis of chronic CSC, and
also as a guide of the size and location to apply the hPDT. IA was also used to detect polypoidal
lesions, and cases of polypoidal choroidal vasculopathy were excluded. The degree of hyper-
fluorescence in the middle phase of IA was classified as intense or intermediate hyperfluores-
cence according to the classification by Inoue et al [24]. The BCVA was measured with a
standard Japanese Landolt visual acuity chart, and the decimal visual acuity was converted to
logMAR units for statistical analyses. All baseline data were obtained within two weeks of the
hPDT.
Spectral domain optical coherence tomography (SD-OCT)
SD-OCTwas performed at each visit with the Heidelberg Spectralis OCT instrument at each
visit. Cross sectional images of 30 degrees through the fovea were obtained by EDI-OCT for
each eye. Each image was obtained through a dilated pupil using the eye tracking system, and
100 scans were averaged to improve the signal-to-noise ratio. Three horizontal and 3 vertical
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scans through the central fovea were performed at each visit by an experienced orthoptist
who was masked to the patients’ clinical findings, and the best images in each direction were
selected by one of the authors (ME) in a masked fashion to be used for the analyses. All
images were obtained between 11:00 and 13:00 hours to minimize the effect of the diurnal
variations in the choroidal structures [32].
The parameters measured were the height of the SRD, the thickness of the neurosensory ret-
ina at the central fovea, the subfoveal choroidal thickness, total choroidal area, and the hypore-
flective and hyperreflective areas of the choroid. The ratio of the hyporeflective area to the total
choroidal area was calculated. The examined area of the subfoveal choroid was 1500 μm wide.
The height of the SRD was set to be the distance between the outer border of the detached neu-
rosensory retina and the inner surface of the RPE. The thickness of the neurosensory retina
was defined as the distance between the vitreoretinal interface and the outer border of the
detached neurosensory retina, and the central choroidal thickness (CCT) as the distance
between the outer border of the RPE and the chorioscleral interface. These distances were mea-
sured by two independent investigators (ME and KS) using the built-in measuring software in
the Heidelberg Spectralis OCT instrument. The averages of two measurements were used for
the statistical analyses.
Evaluation of total choroidal area, hyporeflective and hyperreflective
area by binarization technique
The selected best images were evaluated by one of our authors (ME) in a masked fashion. The
binarization of the choroidal area in the EDI-OCT images was performed by a modified
Niblack method as described in detail [26,30]. Briefly, an EDI-OCT image was analyzed by
freely available software (ImageJ version 1.47, NIH, Bethesda,MD, USA). The subfoveal cho-
roidal area of 1,500 μm wide that extended vertically from the retinal pigment epithelium to
the chorioscleral border was examined. This area was selectedwith the ImageJ ROI Manager.
Three choroidal vessels with lumens>100 μm were randomly selected by the Oval Selection
Tool on the ImageJ tool bar, and the reflectivities of these lumens were averaged. The average
reflectivitywas set as the minimum value to reduce the noise in the OCT image. Then, the
image was converted to 8 bits and adjusted by the Niblack Auto Local Threshold. The binarized
image was converted to the RGB image again. These conversions were technical requirements
for the binarization procedures and the automated calculation by Image J. The hyporeflective
area was determined using the Threshold Tool. The dark pixels were defined as the hyporeflec-
tive areas, and the light pixels were defined as the hyperreflective areas. After adding the data
on the relationship between the distance on the fundus and the pitch of the pixels in the
EDI-OCT images, which depends on the axial length, the hyperreflective and hyporeflective
areas were automatically calculated.
Evaluations of the choroidal areas were also performed for the inner choroid and the outer
choroid. The inner choroid included the choriocapillaris and medium choroidal vessel layer,
and the outer choroid included the larger choroidal vessel layer. The margins of the inner and
the outer choroid were determined by the Branchini et al method with somemodifications
[35]. The segmentation was done on the binarizedOCT images to enhance the margin of the
larger choroidal vessels (Fig 1).
All parameters from the horizontal and vertical images were measured three times, and the
averages of the 6 measurements were used for the data analyses. Although the methods used
for the analysis of the choroid was found to have high repeatability and reproducibility in nor-
mal eyes and eyes with CSC [26, 33, 37], the intra-rater correlation coefficientwas calculated
for the choroidal areas in the EDI-OCT images of CSC eyes at the baseline.
Changes in Choroidal Structures in Eyes with CSC after Photodynamic Therapy
PLOSONE | DOI:10.1371/journal.pone.0163104 September 16, 2016 4 / 15
Half-dose photodynamic therapy
Half-dose PDT (hPDT) was performedwhen a SRD involving fovea was present or was esti-
mated to be present for more than 6 months. Whether a decrease in the visual acuity had
occurredwas not considered as an indication of hPDT. It was done by administering 3 mg/m2
of verteporfin (Visudyne; Novartis, Switzerland) intravenously over a period of 10 minutes as
compared with the normal dose of 6 mg/m2 [18]. Fifteenminutes after the beginning of the
verteporfin infusion, the selected area of the eye was exposed to a 689 nm laser light with an
intensity of 600 mW/cm2 over 83 seconds for a total energy of 50 J/cm2. The treatment spot
size was determined by the area of hyperpermeability in the IA images with an additional
1000 μm around the margin.
Fig 1. Representative enhanced depth imaging optical coherence tomographic (EDI-OCT) images and the converted binary imagesof the
eye of a 55-year-oldmanwith central serous chorioretinopathy (CSC). (A, B, C) EDI-OCT images of the fellow eye (A), treated eye at baseline
(B), and at 3 months after hPDT (C). (D, E, F) The converted binary images of the EDI-OCT images shown in A (D), B (E), and C (F). Themargins of
the region of interest (ROI) are delineated by red lines. Yellow dashed lines indicate the border of the inner and the outer choroid.
doi:10.1371/journal.pone.0163104.g001
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We measured the BCVA, height of the SRD, thickness of the neurosensory retina at the
fovea, CCT, total choroidal area, and the hyporeflective and hyperreflective areas of the choroid
before and 1, 3, and 12 months after the hPDT. The ratio of the hyporeflective area to the total
choroidal area was calculated at each visit.
We have proposed an index called the CSC index that reflects the activity of the disease in
eyes with CSC [33]. The formula of the CSC index was:
CSC index ¼
hyporeflective area of outer choroid
hyperreflective area of outer choroid
hyporeflective area of inner choroid
hyperreflective area of inner choroid
We also evaluated the changes in the CSC index before and after the hPDT.
Statistical analyses
Statistical analyses were carried out with the SPSS version 22 software (IBM, Armonk, New
York, USA). The significance of the differences in the BCVA and the EDI-OCT parameters at
the baseline and at 1 and 3 months was determined by repeated-measures analysis of variance
with Greenhouse-Geisser corrections. The Bonferroni test was used for post hoc analyses. The
significance of the differences between two paired samples was determined by paired t tests.
The significance of the differences between two independent groups was determined by
unpaired t tests. The intra-rater correlation coefficientswere calculated by 1-way random
effectsmodel for measurements of agreement. A two-sided P value of<0.05 was considered
statistically significant.
Results
Baseline demographic data
The baseline demographic data are shown in Table 1. One eye had received an intravitreous
injection of anti-vascular endothelial growth factor agents more than 6 months before the
hPDT. All patients underwent only 1 session of hPDT, and no other treatment including medi-
cal treatments was performed during the study period.All of the 29 eyes were followed for 3
months, and 22 eyes were followed for more than 12 months.
Table 1. BaselineDemographic Data of the PatientswithChronic CSC.
Mean ± SD Range
Sex 22 men / 7 women
Age (yrs) 57.9 ± 9.26 44–82
Refractive Error (diopter) -0.70 ± 2.00 -6.0 - +2.5
Duration of Symptom (median,months) 24 6–120
BCVA (logMAR), (number of letters) 0.16 ± 0.22, (75.72 ± 10.89) -0.079–1.0 (35–85)
Hyperpermeability in IA Intense 14 / intermediate 14
Height of SRD 152.1 ± 82.35 22.5–339.5
Thickness of NeurosensoryRetina 131.9 ± 39.09 73.5–246.0
Diameters of hPDT Treatment Size (μm) 4776.3 ± 1201.1 2150–6500
Values are the means ± SDs unless otherwise indicated.
CSC, central serous chorioretinopathy; SD, standard deviation; BCVA, best-corrected visual acuity; logMAR, logarithmof the minimumangle of resolution;
IA, indocyanine angiography; SRD, serous retinal detachment; hPDT, half-dose photodynamic therapy
doi:10.1371/journal.pone.0163104.t001
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Repeatability of measurement of OCT parameters
The intra-rater agreement was high with an intraclass correlation coefficient>0.9 for the mea-
surements of all of the choroidal parameters (Table 2).
Total, hyporeflective and hyperreflective choroidal areas at baseline
At the baseline, the mean CCT (P<0.001), themean total choroidal area (P<0.001), the mean
hyporeflective area (P<0.001), and the mean hyperreflective area (P = 0.025) of the whole choroid
in the CSC eyes were significantly larger than those of the fellow eyes (Table 3). Themean ratio of
the hyporeflective area to the total choroidal area in the treated eyes was significantly larger than
Table 2. Intra-rateragreement of measurements of choroidal area in eyes withCSC.
ICC 95%CI P-value
Whole Choroid Total Area 0.997 0.995–0.999 P <0.001
Hyporeflective Area 0.994 0.990–0.997 P <0.001
Hyperreflective Area 0.934 0.878–0.967 P <0.001
Inner Choroid Total Area 0.972 0.942–0.987 P <0.001
Hyporeflective Area 0.988 0.975–0.994 P <0.001
Hyperreflective Area 0.967 0.932–0.984 P <0.001
Outer Choroid Total Area 0.994 0.988–0.997 P <0.001
Hyporeflective Area 0.993 0.985–0.997 P <0.001
Hyperreflective Area 0.914 0.821–0.959 P <0.001
CSC, central serous chorioretinopathy; ICC, intraclass correlation coefficients; CI, confidence interval
doi:10.1371/journal.pone.0163104.t002
Table 3. Layer-by-layer analyses of choroidal structuresof treatment eyes and the fellow eyes before and after half-dose PDT.
Fellow eyes Treated eyes
baseline baseline 1M 3M
(N = 24) (N = 29) P-value1 (N = 22) P-value2 (N = 29) P-value3
CCT 310.9 ± 93.7 408.5± 107.9 <0.001 362.1 ± 105.9 <0.001 354.9 ± 110.6 0.001
Whole Choroid Total Area 4.72 ± 1.34 6.14 ± 1.58 <0.001 5.45 ± 1.49 <0.001 5.36 ± 1.63 0.001
Hyporeflective Area 3.24 ± 1.17 4.41 ± 1.40 <0.001 3.86 ± 1.24 <0.001 3.71 ± 1.41 0.003
Hyperreflective Area 1.49 ± 0.23 1.73 ± 0.36 0.025 1.60 ± 0.32 0.075 1.65 ± 0.30 0.897
Hyporeflective / Total Area (%) 67.1 ± 5.87 70.8 ± 5.51 0.020 69.9 ± 4.54 0.030 67.9 ± 5.65 0.009
Inner Choroid Total Area 1.24 ± 0.30 1.33 ± 0.38 0.119 1.21 ± 0.32 0.106 1.21 ± 0.33 0.489
Hyporeflective Area 0.83 ± 0.25 0.78 ± 0.27 0.153 0.76 ± 0.28 1.000 0.73 ± 0.27 1.000
Hyperreflective Area 0.43 ± 0.11 0.55 ± 0.08 <0.001 0.45 ± 0.09 0.003 0.48 ± 0.10 0.002
Hyporeflective / Total Area (%) 65.8 ± 7.22 57.1 ± 6.57 <0.001 61.1± 8.90 0.066 59.3 ± 7.95 0.011
Outer Choroid Total Area 3.48 ± 1.11 4.78 ± 1.40 <0.001 4.25 ± 1.29 0.001 4.13 ± 1.39 0.002
Hyporeflective Area 2.41 ± 0.98 3.61 ± 1.24 <0.001 3.11 ± 1.05 0.001 2.96 ± 1.21 0.001
Hyperreflective Area 1.07 ± 0.21 1.12 ± 0.33 0.578 1.14 ± 0.31 1.000 1.17 ± 0.27 1.000
Hyporeflective / Total Area (%) 67.3 ± 7.60 74.1 ± 6.29 <0.001 72.5 ± 4.49 0.005 70.2 ± 5.87 0.003
Values are the mean ± SDs (x 105 μm2).
CSC, central serous chorioretinopathy; SD, standard deviation; CCT, central choroidal thickness
1Significance between fellow eyes and treated eyes at baseline
2Significance in the treated eyes between baseline and 1 month after the half-dosePDT
3Significance in the treated eyes between baseline and 3 months after the half-dose PDT
doi:10.1371/journal.pone.0163104.t003
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that in the fellow eyes (P = 0.020). The mean hyperreflective area of the inner choroid of the CSC
eyes was significantly larger than that in the fellow eyes (P<0.001). However, the hyporeflective
area of the inner choroid was not significantly different from that of the fellow eyes (P = 0.153).
Themean hyporeflective area of the outer choroid was significantly larger than that in the fellow
eyes (P<0.001), but themean hyperreflective area of the outer choroid was not significantly differ-
ent from that of the fellow eyes (P = 0.578). A representative case is shown in Fig 1.
Time course of changes in the BCVA and the retinal morphological
parameters
The mean BCVA at 3 months was 0.065 ± 0.204 logMAR units (81.7 ± 10.42 letters in ETDRS
visual acuity charts) which was significantly better than that at the baseline (P = 0.022, Fig 2),
and this improvement was maintained at 0.04 ± 0.172 (82.9 ± 8.76 letters) at 12 months. The
SRD was completely resolved in 26 eyes (89.7%) at 3 months. Of the 3 eyes with SRDs at 3
months, the SRDs were still present in 2 eyes at 12 months, and 1 eye was lost to follow-up. No
recurrence of the SRD was observed in the eyes for at least 12 months. The mean thickness of
the neurosensory retina at 3 months was 147.4± 37.48 μm, which was significantly thicker than
that at baseline (P = 0.038).
Time course of changes in choroidal morphologicalparameters of whole
choroid in treated eyes
The mean CCTwas significantly decreased at 1 month (P<0.001) and at 3 months (P = 0.001;
Fig 3, Table 3, S1 Table). The mean CCT at 12 months was not significantly different from that
Fig 2. Scattered plots showing the associationsbetweenBCVA at the baselineand that at 3 months.No eye was
worsened10 letters at 3 months comparedwith that at baseline. The data of 7 eyes were overlapped each other in this
scattered plots.
doi:10.1371/journal.pone.0163104.g002
Changes in Choroidal Structures in Eyes with CSC after Photodynamic Therapy
PLOSONE | DOI:10.1371/journal.pone.0163104 September 16, 2016 8 / 15
at 3 months (P = 0.291). The mean total choroidal area of the whole choroid was significantly
decreased from that at baseline at 1 month (P<0.001) and at 3 months (P = 0.001). The mean
total choroidal area at 12 months was not significantly different from that at 3 months
(P = 0.149).
The hyporeflective area of whole choroid was significantly decreased from that at the base-
line at 1 month (P<0.001) and at 3 months (P = 0.003). However, the hyporeflective area of
whole choroid at 12 months was not significantly different from that at 3 months (P = 0.090).
There was no significant change in the mean hyperreflective area of the whole choroid during
the study period (P = 0.083).
The ratio of hyporeflective area to choroidal area of whole choroid was significantly
decreased from that at baseline at 1 month (P = 0.030) and at 3 months (P = 0.009). The ratio
at 12 months was 67.5 ± 6.00% which was not significantly different from that at 3 months
(P = 0.815). The ratios of normal controls was 65.2 ± 3.28% which was significantly lower than
that of CSC eyes at the baseline (P<0.001, S2 Table), at 1 month (P<0.001), and at 3 months
(P = 0.033), but was not significantly different from that at 12 months (P = 0.116).
Time course of changes in different layers of choroid
In the inner choroid, there was no significant change in the total choroidal area and hyporeflec-
tive area during the follow-up periods (P = 0.103 and P = 0.718, Fig 4). However, the hyperre-
flective area of the inner choroid was significantly decreased from baseline at 1 month
(P = 0.003) and at 3 months (P = 0.002). The ratio of the hyporeflective area to total choroidal
area in the inner choroid was significantly increased from that at the baseline at 3 months
(P = 0.011).
In the outer choroid, the total choroidal area was significantly decreased from that at the
baseline at 1 month and at 3 months (P = 0.001 and P = 0.002). The hyporeflective area was
also significantly decreased from the baseline value at 1 month and at 3 months (P = 0.001,
Fig 3. Time course of changes in EDI-OCTparameters. All parameters except the hyperreflective areaswere significantly
decreased from the baseline at 1 month and thereafter. Data are presented relative to that at the baseline. *P <0.001, #P <0.01,
†P <0.05.
doi:10.1371/journal.pone.0163104.g003
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both). However, there was no significant difference in the hyperreflective areas at any time dur-
ing the 3-month follow-up period (P = 0.700). The ratio of the hyporeflective area to total cho-
roidal area in the outer choroid was significantly decreased at 1 month (P = 0.005) and at 3
months (P = 0.003).
Time course of changes in choroidal morphologicalparameters in the
fellow eyes
There was no significant difference between all of the choroidal parameters of the whole, inner,
and outer choroid at the baseline and those at 3 months in the untreated fellow eyes (P
>0.100).
The CSC index
At the baseline, the mean CSC index in the treated eyes was 2.36 ± 0.89 which was significantly
higher than that in the 24 fellow eyes without a SRD at 1.24 ± 0.63 (P<0.001). The index was
significantly reduced to 1.71 ± 0.60 at 1 month (P = 0.010), and 1.72 ± 0.60 at 3 months
(P = 0.002). The index was 1.48 ± 0.60 at 12 months, which was significantly lower than that at
3 months (P = 0.035). The index at 12 months was not different from that in fellow eyes at
baseline (P = 0.215), however, it was significantly larger than that in age-, sex-, and refractive
error-matched normal controls (the index = 0.99 ± 0.37, P = 0.002, S2 Table).
Relationship between choroidal morphologicalparameters and
indocyanine green angiographic findings
At the baseline, the CCT, the total choroidal area, and the hyporeflective area of whole choroid
were significantly larger in the eyes with intense hyperfluorescence in IA images than in the
eyes with intermediate hyperfluorescence (P = 0.038, P = 0.046, and P = 0.033), The total cho-
roidal area and the hyporeflective area of the outer choroid were significantly larger in the eyes
with intense hyperfluorescence than in the eyes with intermediate hyperfluorescence
(P = 0.015 and P = 0.021).
In the 3 eyes with a persistent SRD at 3 months, 2 eyes had intermediate hyperpermeability
in the IA at the baseline, and one eye had intense hyperpermeability at the baseline. However,
none of these distributions was significant (P = 1.000, Fisher’s exact test). There was no signifi-
cant correlation between the presence of persistent SRD and the choroidal parameters.
Fig 4. Time course of changes in EDI-OCTparameters in different layers of choroid In the inner choroid, themean
hyperreflective area but not themean hyporeflective area was significantly decreased at 1 month and thereafter. In
the outer choroid, the hyporeflective but not the hyperreflective area was significantly decreased at 1 month and thereafter.
The CSC index was significantly decreased at 1 month and thereafter. The values of the choroidal areas are presented
relative to that at the baseline. *P <0.001, #P <0.01.
doi:10.1371/journal.pone.0163104.g004
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Discussion
At the baseline, the CCT and total choroidal area of the whole choroid were significantly larger
in the treated eyes than in the fellow eyes. These changes were associated with increases in both
the hyperreflective area of the inner choroid and the hyporeflective area of the outer choroid.
Because the hyperreflective areas correspond to the choroidal stroma and the hyporeflective
areas to the choroidal vessels, these results are consistent with the earlier studies which
reported that the increased choroidal thickness in eyes with CSC was associatedwith the hyper-
permeability of the choriocapillaris and dilation of the larger choroidal vessels [2, 10, 39].
We reported earlier that the hyporeflective area but not the hyperreflective area in the outer
choroid in the CSC eyes was significantly larger than that of the fellow eyes and normal eyes
[33]. In addition, the hyporeflective area in the outer choroid in the fellow eyes was signifi-
cantly larger than that in normal eyes. On the other hand, the hyperreflective area but not the
hyporeflective area in the inner choroid of the CSC eyes was significantly larger than that of
the fellow eyes, and the hyperreflective area in the inner choroid in the fellow eyes was not sig-
nificantly different from that in normal eyes. These results suggest that the increase in the
hyporeflective area of the outer choroid which corresponds to the dilation of the larger choroi-
dal vessels may be a basic characteristic of the CSC disease process. In addition, the increase in
the hyperreflective area of the inner choroid which corresponds to the swelling of the stroma
may be the subsequent pathological change in eyes with CSC. The results of this study regard-
ing chronic CSC at baseline confirmed the findings of our previous reports on acute CSC [33].
After the hPDT, the CCT and total choroidal area of the whole choroid were significantly
decreased, and these changes were associated with a decrease in the hyperreflective area of the
inner choroid and the hyporeflective area of the outer choroid. Chan et al reported that choroi-
dal permeability and dilation of the larger choroidal vessels were decreased in the IA images
after PDT in eyes with CSC [16]. Histopathological study of eyes with CSC in animals showed
damage of the endothelial cells of the choriocapillaris and extensive leakage of fibrin into the
stroma of the inner choroid [40]. One of the characteristic histopathological changes following
PDT in human eyes is the occlusion of the choriocapillaris [41]. Our results are consistent with
the IA and histopathological findings after PDT. It is believed that reducing the choroidal
hyperpermeability is the main mechanism for the effectiveness of PDT on the serous retinal
detachment in eyes with CSC [16]. The decrease in the hyperreflective area of the inner choroid
may represent the decrease in the stromal swelling associated with the decrease in the hyper-
permeability of choriocapillaris after hPDT. Layer-by-layer analysis was needed to determine
the consistency between the morphological changes in the EDI-OCT images and the changes
in the IA images and histopathological findings because the hyperreflective area of the whole
choroid was not significantly changed after hPDT.
Although the mechanism causing the reduction of the hyporeflective area in the outer cho-
roid was not determined, one possible explanation could be that the decrease in the hydrostatic
pressure that results from the decrease in the swelling of the stroma reduced the peripheral vas-
cular resistance, which then relieved the congestion of the choroidal vessels. Another explana-
tion may be that the decrease in the hyporeflective area of the outer choroid was accompanied
by a decrease in the fluid-filled spaces of the outer choroid. Spaide and Ryan reported that
there were hyporeflective areas of fluid loculation in the outer choroid of CSC eyes [34]. Fur-
ther studies using multimodal imaging that can evaluate the choroidal circulation with
improved OCT technologies are needed.
We recently proposed a CSC index to represent the activity of the CSC. The index increases
along with an increase in the size of the hyperreflective area of the inner choroid and the hypor-
eflective area of the outer choroid. In fact, the index was largest in eyes with active CSC with a
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SRD, intermediate in the fellow eyes of patients with unilateral active CSC, and lowest in nor-
mal eyes [33]. In this study, the index was significantly larger in the preoperative treated eyes
than in the fellow eyes at the baseline, and decreased significantly at 1 month after the hPDT
and continued to decrease until 12 months. However, the index at 12 months was significantly
higher than that in normal controls. These results suggest that the structural abnormalities of
choroid persisted even after the hPDT resolved the SRD at 12 months. The ratio of hyporeflec-
tive area to the total choroidal area of whole choroid was also decreased after the hPDT, but it
may be less sensitive to the activity of the disease than the CSC index. At the baseline, the sig-
nificance of the differences between the CSC eyes and the fellow eyes were larger in the CSC
index (P<0.001) than in the ratio (P = 0.030). In addition, the index of the CSC eyes at 12
months was significantly larger than the normal control eyes (P = 0.002), but the ratio of the
CSC eyes at 12 months was not significantly different from that of the normal control
(P = 0.116).
At the baseline, the central choroidal thickness, total choroidal area, and hyporeflective area
of whole choroid were significantly larger in the eyes with intense hyperfluorescence in IA
images than in the eyes with intermediate hyperfluorescence. This may be because the activity
of the disease in eyes with intense hyperfluorescencemay be higher than that in the eyes with
intermediate hyperfluorescence.
There are some limitations in this study. First, a retrospective study can have sampling
biases. Second, the sample size was small. Third, the follow-up period of 12 months may have
been too short, and only 22 eyes (75.9%) completed the 12 months of follow-up. Lastly, manual
segmentation of the inner and outer choroid is not completely objective. However, to the best
of our knowledge, this is the first study that evaluated the changes in the choroidal structures
in eyes with CSC before and after the hPDT using layer-by-layer analyses.
In conclusion, the subfoveal choroidal area was significantly decreased after hPDT, which
was most likely due to a decrease in the exudative changes in the inner choroid and a reduction
in the dilation of larger vessels in the outer choroid.
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